This review reinforces the relationship between hepatic steatosis and metabolic dysfunction and the importance of multifactorial understanding for its management.
Post
Tag: Steatotic liver disease; metabolic dysfunction-associated steatotic liver disease; MASLD; liver fibrosis; metabolic syndrome; genetic polymorphisms; drug therapy
